Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

Progression-free survival is an important end point in advanced disease settings. Blinded independent central review (BICR) of progression in randomized clinical trials has been advocated to control bias that might result from errors in progression assessments. However, although BICR lessens some po...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dodd, Lori E., Korn, Edward L., Freidlin, Boris, Jaffe, C. Carl, Rubinstein, Lawrence V., Dancey, Janet, Mooney, Margaret M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2008
Konular:
Statistics in Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654812/
https://ncbi.nlm.nih.gov/pubmed/18669467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.1711
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller